Patent application number | Description | Published |
20130150343 | KINASE INHIBITORS - Compounds of formula (I) and pharmaceutically acceptable salts thereof: | 06-13-2013 |
20130150361 | KINASE INHIBITORS - Compounds of formula (I): | 06-13-2013 |
20140171414 | NOVEL COMPOUNDS - Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HNE is implicated. | 06-19-2014 |
20140323470 | KINASE INHIBITORS - Compounds of formula (I) and pharmaceutically acceptable salts thereof: | 10-30-2014 |
20140343055 | KINASE INHIBITORS - Compounds of formula (I): | 11-20-2014 |
20140364411 | KINASE INHIBITORS - Compounds of formula (I) described herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract. | 12-11-2014 |
20140364412 | KINASE INHIBITORS - Compounds of formula (I) described herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract | 12-11-2014 |
20150080375 | KINASE INHIBITORS - Compounds of formula (I) and pharmaceutically acceptable salts thereof: | 03-19-2015 |